Text Size A A A

Sun Pharma In The News

Tell a Friend Print Home » Media » Sun Pharma In The News

Sun settles patent row with Orion

 

 
Sun Pharma'ceutical Industries on Tuesday said it has settled a patent litigation with Fin'land-based Orion over generic versions of Stalevo and Comtan tablets, which are used for the treatment of Parkinson's disease.
 
Besides, the firm also said it has got approval from the US Food and Drugs Administration to sell generic version of Optivar, indicated for itching of the eyes, in the US market.
 
Sun Pharma said it has executed a settlement agreement with Orion that would enable it to launch the generic ver'sions of Stalevo and Comtan in multiple strengths in the US, as early as April 1,2012.
 
"Under the agreement, Sun Pharma will be able to launch generic versions of Stalevo tablets in strengths of 25/100/200mg and 37.5/150/200 mg in the US on April 1,2012," the company said. In addition, Sun Pharma will be able to launch generic versions of other strengths of Stalevo products on October 2,2012.